000 | 01905 a2200553 4500 | ||
---|---|---|---|
005 | 20250516100910.0 | ||
264 | 0 | _c20121221 | |
008 | 201212s 0 0 eng d | ||
022 | _a1873-4596 | ||
024 | 7 |
_a10.1016/j.freeradbiomed.2012.06.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPatir, Himadri | |
245 | 0 | 0 |
_aQuercetin as a prophylactic measure against high altitude cerebral edema. _h[electronic resource] |
260 |
_bFree radical biology & medicine _cAug 2012 |
||
300 |
_a659-68 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAltitude |
650 | 0 | 4 |
_aAltitude Sickness _xprevention & control |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 | _aAtmospheric Pressure |
650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aBrain Edema _xblood |
650 | 0 | 4 | _aChemoprevention |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aHypoxia _xblood |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMountaineering |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aQuercetin _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
700 | 1 | _aSarada, S K S | |
700 | 1 | _aSingh, Saumya | |
700 | 1 | _aMathew, Titto | |
700 | 1 | _aSingh, Bhagwat | |
700 | 1 | _aBansal, Anju | |
773 | 0 |
_tFree radical biology & medicine _gvol. 53 _gno. 4 _gp. 659-68 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.freeradbiomed.2012.06.010 _zAvailable from publisher's website |
999 |
_c21903803 _d21903803 |